ELAINE ARCHULETA: Open Payments
NPI 1760556310 · OGDEN, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$596 in 27 payments from 11 companies in 2025. Trend: 2023 $902 · 2024 $750 · 2025 $596
Food & beverage: $596
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 9 | $219 |
| E.R. Squibb & Sons, L.L.C. | 5 | $106 |
| Novartis Pharmaceuticals Corporation | 4 | $81 |
| CVRx, Inc. | 1 | $42 |
| Actelion Pharmaceuticals US, Inc. | 2 | $37 |
| SCPHARMACEUTICALS INC. | 1 | $29 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| Boston Scientific Corporation | 1 | $16 |
| Tactile Systems Technology Inc | 1 | $14 |
Products named: ELIQUIS, VYNDAQEL, LEQVIO, VYNDAMAX, CAMZYOS, Barostim Neo System, FUROSCIX, Kerendia.
Industry payments across UT — which companies pay providers there.
